Revvity Board Declares Quarterly Dividend
January 25 2024 - 4:15PM
Business Wire
The Board of Directors of Revvity, Inc. (NYSE: RVTY), today
declared a regular quarterly dividend of $0.07 per share of common
stock. This dividend is payable on May 10, 2024 to all shareholders
of record at the close of business on April 19, 2024.
About Revvity
At Revvity, “impossible” is inspiration, and “can’t be done” is
a call to action. Revvity provides health science solutions,
technologies, expertise and services that deliver complete
workflows from discovery to development, and diagnosis to cure.
Revvity is revolutionizing what’s possible in healthcare, with
specialized focus areas in translational multi-omics technologies,
biomarker identification, imaging, prediction, screening, detection
and diagnosis, informatics and more.
With 2022 revenue of more than $3 billion and over 11,000
employees, Revvity serves customers across pharmaceutical and
biotech, diagnostic labs, academia and governments. It is part of
the S&P 500 index and has customers in more than 190
countries.
Stay updated by following our Newsroom, LinkedIn, X, YouTube,
Facebook and Instagram.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240125311370/en/
Media Relations: Chet Murray (781) 462-5126
chet.murray@revvity.com
Investor Relations: Steve Willoughby
steve.willoughby@revvity.com
Revvity (NYSE:RVTY)
Historical Stock Chart
From May 2024 to Jun 2024
Revvity (NYSE:RVTY)
Historical Stock Chart
From Jun 2023 to Jun 2024